Skip to main content

Perlegen to Conduct Second Genotyping Study for AstraZeneca

NEW YORK, Jan. 24 (GenomeWeb News) - Perlegen Sciences will conduct a second genotyping study for AstraZeneca, the Mountain View, Calif.-based company said today.

 

Under the agreement, Perlegen will determine SNPs in individuals with an undisclosed trait of interest as well as in controls.

 

One year ago, the two companies announced their first collaboration to study the genetics of myocardial infarction.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.